Bliss GVS Pharma Ltd Financial Statements

BLISSGVS Profit and Loss

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Revenue 747 577 689 815
yoy growth (%) 29.50 (16) (15) 2.03
Raw materials (391) (329) (440) (391)
As % of sales 52.30 57 63.80 48
Employee costs (76) (68) (54) (69)
As % of sales 10.20 11.80 7.79 8.50
Other costs (162) (74) (72) (157)
As % of sales 21.70 12.70 10.50 19.30
Operating profit 118 107 123 197
OPM 15.80 18.50 17.90 24.20
Depreciation (17) (17) (13) (21)
Interest expense (4.70) (5.50) (5.40) (23)
Other income 31.50 20.20 37.10 26.50
Profit before tax 128 104 142 179
Taxes (31) (30) (34) (57)
Tax rate (24) (29) (24) (32)
Minorities and other (8.10) (5.50) 2.01 (30)
Adj. profit 88.60 68.50 111 93
Exceptional items (74) -- (13) (34)
Net profit 15 68.50 97.30 58.80
yoy growth (%) (78) (30) 65.50 (28)
NPM 2.01 11.90 14.10 7.22

Invest wise with Expert advice

Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp